Zevra Niemann-Pick Disease Type C Drug Miplyffa Now Available

Seeking Alpha06:29

Johnson & Johnson Announces Health Canada Authorizes CARVYKTI For Patients With Relapsed Or Refractory Multiple Myeloma Who Have Received 1-3 Prior Lines Of Therapy, Including A Proteasome Inhibitor And An Immunomodulatory Agent, And Who Are...

Benzinga05:14

Oppenheimer Asset Management Spotlights Buy Calls on WMT, VRT, and MOD

Seeking Alpha03:29

'Three Bank Of America Bankers In India Depart Over Alleged Client Tips' - Financial Times

Benzinga02:57

Optimism Over Global Healthcare Sector Rises: Jefferies

Seeking Alpha02:45

8 Financials Stocks Whale Activity In Today's Session

Benzinga01:35